Opaleye Management Inc.'s Form 4 filing
Grace Therapeutics, Inc. (GRCE) · filed Aug 19, 2026
- Accession no.
- 0001493152-26-039124
- Filed
- Aug 19, 2026, 7:44 AM ET
- Trade date
- Aug 14, 2026
- Filing delay
- 5 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market purchases total $24.2K. It was filed 5 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Opaleye Management Inc.CIK 0001595855 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 14, 2026 | Common Stock, par value $0.0001 per share | PPurchaseAcquired | +11,608 | $2.09 | +$24,206.16 | 2,760,000 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.